Study design
MDD
The RESET-psychotherapy study is a 12-week, multicenter, single-blind, superiority RCT with two treatment arms: 1) TAU and 2) TAU + TFT. In total, 158 adult MDD patients with CT are randomly allocated (1:1) to one of the two treatment conditions (see ‘